Zobrazeno 1 - 10
of 126
pro vyhledávání: '"PH Cottu"'
Autor:
F-C Bidard, C. Simondi, Delphine Loirat, Frédérique Berger, Véronique Diéras, J-Y Pierga, PH Cottu, William Jacot, J-M Ferrero, Thomas Bachelot, Marc Espié, Catherine Alix-Panabières, Sylvain Ladoire, Sylvain Dureau, C. Levy, H Bourgeois, Florence Dalenc, Joseph Gligorov, A. Gonçalves, E. Brain, H. Naman
Publikováno v:
Cancer Research. 79:GS3-07
Background: In ER+ HER2- metastatic breast cancer (MBC) patients, the clinical choice between 1st line hormone therapy (HT, the recommended option) or chemotherapy (CT) is based on the absence of “visceral crisis” or adverse prognostic factors, w
Autor:
PH Cottu, C. Levy, A Gobillion, K Peignaux, B. De La Lande, A. Clément-Zhao, C. Lemanski, P. Bontemps, M-L Tanguy, A Reynaud-Bougnoux, Y.M. Kirova, P Baumann
Publikováno v:
Cancer Research. 79:P3-12
Background and Purpose: Recent phase 3 clinical trials have evaluated the addition of bevacizumab (B) to standard chemotherapy in the treatment of patients with non-metastatic breast cancer. But few data are available about the tolerance of B with lo
Autor:
Jérôme Lemonnier, Véronique Verriele, J-P Ghnassia, J.-M. Guinebretiere, PH Cottu, Juliette Haudebourg, S Delaloge, Laurent Arnould, A Berghian, M-C Mathieu, A Vincent-Salomon, Paul Delrée, A Maran-Gonzalez, V Calès, R Duprez, Frédérique Penault-Llorca, Celine Lefebvre, Guillaume Bataillon, Cécile Blanc-Fournier, Christine Galant
Publikováno v:
Cancer Research. 79:P4-15
Background The role of chemotherapy in early luminal breast cancer remains challenged. The NEOPAL trial (NCT 02400567; Cottu et al, ESMO 2017 LBA09) compared sequential chemotherapy (CT) and letrozole-palbociclib (LP) as neoadjuvant treatment in PAM5
Autor:
Lionel Uwer, Christelle Jouannaud, M. Campone, Florence Dalenc, J-M Ferrero, Bruno Coudert, A. Gonçalves, Audrey Lardy-Cleaud, François Bertucci, Audrey Mailliez, Gaëtane Simon, Barbara Pistilli, Florence Lerebours, Thomas Bachelot, Patrice Viens, M. Robain, T. de La Motte Rouge, A. Monneur, Marc Debled, C. Levy, M.-A. Mouret-Reynier, Séverine Guiu, Paule Augereau, Thierry Petit, M. Leheurteur, PH Cottu
Publikováno v:
Cancer Research. 79:P5-17
Background:Primary inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer. Survival of IBC patients has been improved by multimodal therapy. However 5-year overall survival (OS) still remains close to 50-60%, due to high risk
Autor:
C. Levy, Olivier Tredan, JL Baker, Patrick Soulié, Patrick Arveux, Laurence Vanlemmens, NM Iyengar, Stefan Michiels, A Fabrice, A. Lesur, PH Cottu, L. Jones, Charles Coutant, M El Mouhebb, Sibille Everhard, Christelle Jouannaud, A. Di Meglio, I. Vaz Luis, Florence Lerebours, A-L. Martin
Publikováno v:
Cancer Research. 79:P1-15
Background: Randomized trials, although not all, suggest exercise therapy improves treatment completion rates / relative dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy (CT). In addition, preclinical studies
Autor:
PH Cottu, J-P. Jacquin, Sylvie Chabaud, M. Campone, J. Grenier, Marc Debled, E. Brain, D. Allouache, Thomas Bachelot, David Cameron, F. Del Piano, Sylvie Giacchetti, Jérôme Lemonnier, Judith M Bliss, M. Brunt, L. Venat Bouvet, Florence Dalenc, Fabrice Andre, J-L Canon, A-C. Hardy Bessard
Publikováno v:
Annals of Oncology. 32:574-575
Autor:
Patrick Soulié, Y Amar, Christelle Jouannaud, Olivier Tredan, Patrick Arveux, Antoine Arnaud, Olivier Rigal, H Bonsang-Kitzis, Alexia Savignoni, Laurence Vanlemmens, PH Cottu, A. Lesur, Barbara Pistilli, F Andre, M. Fournier, Florence Lerebours, Christine Levy, Christel Mesleard, Olivier Arsene, Sylvie Giacchetti
Publikováno v:
Cancer Research. 78:P6-12
Background There is no large prospective trial assessing mid-term adverse effects of adjuvant chemotherapy. In order to address this question, we developed CANTO (CANcer TOxicities - NCT01993498 - http://etudecanto.org/), a prospective trial dedicate
Autor:
M. Campone, A. Gonçalves, L. Roca, A Zingarello, Sofia Rivera, H. Roche, Bruno Coudert, J-C Eymard, S Delaloge, Chafika Mazouni, Jérôme Lemonnier, J-L Canon, C. Tunon de Lara, Thomas Bachelot, Magali Lacroix-Triki, PH Cottu, Thomas Filleron, Daniel Serin, Christine Levy, Barbara Pistilli, Thierry Petit
Publikováno v:
Cancer Research. 78:P1-07
Purpose:Incidence of LRs in patients (pts) treated for HR+ HER2- localized BC and distribution overtime have not been described in recent years after introduction of new generation of adjuvant therapies and more extensive use of radiotherapy. We eval
Autor:
Christine Levy, Florence Lerebours, J-S. Frenel, J-M Ferrero, J. Grenier, PH Cottu, M-A Mouret-Reynier, F Duhouix, Christelle Jouannaud, Isabelle Desmoulins, Pierre-Etienne Heudel, Sylvain Dureau, Jérôme Lemonnier, Véronique D'Hondt, L. Venat-Bouvet, J-L Canon, S Delaloge, Florence Dalenc, A Vincent-Salomon, S. Nguyen
Publikováno v:
Cancer Research. 78:P3-13
This abstract was withdrawn by the authors.
Autor:
A. Gonçalves, Christine Levy, J-M Ferrero, M. Campone, M. Leheurteur, M. Robain, Claudia Lefeuvre, Audrey Mailliez, Marc Debled, Lionel Uwer, PH Cottu, M-A Mouret-Reynier, Barbara Pistilli, J-C Eymard, William Jacot, Florence Dalenc, M. Chaix, C. Courtinard, P-E. Heudel, S Gourgou, Séverine Guiu, Julien Fraisse, Thierry Petit
Publikováno v:
Cancer Research. 78:P6-14
Background: In 2014, UNICANCER (composed of 18 French Comprehensive Cancer Centers) launched the Epidemiological Strategy and Medical Economics (ESME) program to investigate real-world data in solid tumors. Real-world data give the opportunity to ass